Qi Zhao - Publications

Pan-cancer analysis reveals the oncogenic and immunomodulatory roles of PTGFRN across human cancers.

Journal: Scientific reports

Published: October 21, 2025

Tumor-Infiltrating Mast Cells Enhance Neoadjuvant Therapy Efficacy in ESCC via Modulation of the Desmoplastic Microenvironment.

Journal: OncoTargets and therapy

Published: August 29, 2025

The prognostic value of tumor deposits in esophageal squamous cell carcinoma: A propensity score matching study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: June 08, 2025

Perioperative outcomes of neoadjuvant chemotherapy plus camrelizumab versus neoadjuvant chemotherapy plus tislelizumab for locally advanced esophageal squamous cell cancer: a real-world retrospective study.

Journal: Frontiers in immunology

Published: December 13, 2024

A pan-cancer analysis of the oncogenic and immunological roles of THOC3 in human cancer.

Journal: Scientific reports

Published: September 18, 2024

Association between surgery treatment delays and survival outcomes in patients with esophageal cancer in Hebei, China.

Journal: Frontiers in oncology

Published: July 12, 2024

The Survival and Prognosis Characteristics of Primary Esophageal Small-Cell Carcinoma.

Journal: Disease markers

Published: May 05, 2022

Folate Receptor 4-Expressing T cell Is Associated with Disease-Free Survival in Patients with Esophageal Squamous Cell Carcinoma.

Journal: Disease markers

Published: April 21, 2022

POC1A, prognostic biomarker of immunosuppressive microenvironment in cancer.

Journal: Aging

Published: March 06, 2022

P4HA1, a Prognostic Biomarker that Correlates With Immune Infiltrates in Lung Adenocarcinoma and Pan-Cancer.

Journal: Frontiers in cell and developmental biology

Published: August 06, 2021